4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-23-016054
Head of R&D, CSO gave up 522 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Rodino-Klapac Louise · Head of R&D, CSO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-03-01 | Shares withheld for taxes : show line 1 in the form | −522 | $147.57 | $77,032 | 67,716 | D |
Loading xslF345X03/doc4.xml…